NKTX

Nkarta, Inc. is a leading clinical-stage biopharmaceutical company based in South San Francisco, California, focused on the development of advanced cell therapies for cancer. Utilizing its proprietary technology platform, Nkarta is innovating therapies that harness the power of the immune system to efficiently target and eliminate cancer cells. With a robust pipeline of product candidates across various clinical stages, the company is strategically positioned to address critical unmet needs in oncology and advance the landscape of cancer treatment.